Coagulation Factor XIII

At IntroLab, we offer a precise analysis of coagulation factor XIII, which helps diagnose blood clotting disorders. Our expert team provides fast and reliable results for an accurate medical assessment.

What is coagulation factor XIII?

Coagulation factor XIII is a protein in the blood involved in the final stage of clotting. It stabilizes the formed blood clot by converting fibrin into a solid network, preventing excessive bleeding. Without factor XIII, blood clots would be weaker and prone to breaking down, potentially leading to prolonged bleeding.

When is testing for coagulation factor XIII necessary?

Testing for coagulation factor XIII is recommended for patients who experience unexplained or prolonged bleeding, have a tendency to bruise easily, or when there is suspicion of inherited clotting disorders, such as hemophilia or a deficiency of this factor. Additionally, in individuals prone to thrombosis, abnormal activity of factor XIII may be the cause of blood clot formation.

How is the test performed?

The test involves taking a blood sample, which is then analyzed to determine the functionality of factor XIII. This analysis provides important information about potential clotting disorders and allows doctors to take further steps in diagnosis and treatment.

Deficiency of coagulation factor XIII

A deficiency of this factor can lead to serious blood clotting disorders. Individuals with this deficiency often suffer from prolonged bleeding, spontaneous bruising, and increased bleeding after injuries or surgeries. In severe cases, a deficiency in factor XIII can result in intracranial bleeding or other complications.

Inherited and acquired disorders

A deficiency of factor XIII can be caused by inherited disorders, which are rare but serious, or it can be acquired later in life due to certain conditions such as leukemia, severe infections, or autoimmune diseases.

Other coagulation factor tests

In addition to the analysis of coagulation factor XIII, IntroLab also offers the following tests, which help assess the coagulation system:

• Coagulation Factor II (Prothrombin) – Converts into thrombin, which allows the conversion of fibrinogen into fibrin.
• Coagulation Factor V – Assists in the formation of prothrombinase, which activates prothrombin.
• Coagulation Factor VII – Activates the extrinsic coagulation pathway, enabling the activation of factor X.
• Coagulation Factor VIII – Necessary for the intrinsic coagulation pathway; its deficiency causes hemophilia A.
• Coagulation Factor IX – Participates in the intrinsic coagulation pathway; its deficiency causes hemophilia B.
• Coagulation Factor X – Involved in the conversion of prothrombin into thrombin in the common coagulation pathway.
• Coagulation Factor XI – Activates factor IX in the intrinsic coagulation pathway.
• Coagulation Factor XII – Triggers the intrinsic coagulation pathway, although its deficiency rarely causes symptoms.

These analyses provide a detailed overview of all stages of coagulation and help identify blood clotting disorders.